IDEAS home Printed from https://ideas.repec.org/a/sae/medema/v27y2007i2p138-150.html
   My bibliography  Save this article

Costs of Rheumatoid Arthritis: New Estimates from the Human Capital Method and Comparison to the Willingness-to-Pay Method

Author

Listed:
  • Bruno Fautrel

    (Department of Rheumatology, University of Paris VI-Pierre et Marie Curie, Hospital Pitié-Salpêtrière, Paris, France, Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada, EA 3444, School of Public Health, Faculty of Medicine, Nancy, France, bruno.fautrel@psl.ap-hop-paris.fr)

  • Ann E. Clarke

    (Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada)

  • Francis Guillemin

    (EA 3444, School of Public Health, Faculty of Medicine, Nancy, France)

  • Viviane Adam

    (Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada)

  • Yvan St-Pierre

    (Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada)

  • Tina Panaritis

    (Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada)

  • Paul R. Fortin

    (Department of Rheumatology, University of Toronto, Toronto, ON, Canada)

  • Henri A. Menard

    (Department of Rheumatology, McGill University Health Center, Montreal, QC, Canada)

  • Cam Donaldson

    (Institute of Health and Society, University of Newcastle, UK)

  • John R. Penrod

    (Division of Clinical Epidemiology, McGill University Health Center, Montreal, QC, Canada)

Abstract

Background . Individuals' valuation of changes in health states in monetary terms have been measured by examining changes in the direct and indirect costs of disease and by the willingness-to-pay (WTP) methodology. Methods . In 2002, a 2-part study was conducted in Quebec. In one part of the study, 121 rheumatoid arthritis (RA) patients from the McGill University Health Centre were mailed the Stanford Cost Assessment Questionnaire, which enabled the elicitation of direct costs and indirect costs, according to the friction cost and the human capital methods. The other part was a phone survey conducted in a representative sample of the general population and in the same sample of patients, aiming to elicit the societal WTP for a complete cure of RA in the context of 2 different scenarios: a public coverage or private insurance. These estimates were then compared. Results . Estimates of the cost of illness of RA ranged from 11,717 to 28,498 Canadian Dollars (CAD) depending on the method. These estimates are higher than those previously published in Canada from the 1990s, which is partly due to the recent and costly biological therapies and to a change in the measurement of productivity losses. These estimates are somewhat lower than the societal WTP elicited from the WTP survey, that is, 26,717 and 36,817 CAD per RA case, depending on the public or private health insurance context in which the cure would be available. Conclusion . Given that neither method is ideal, data from both methods would provide an important sensitivity analysis when monetary estimates of health state changes are required.

Suggested Citation

  • Bruno Fautrel & Ann E. Clarke & Francis Guillemin & Viviane Adam & Yvan St-Pierre & Tina Panaritis & Paul R. Fortin & Henri A. Menard & Cam Donaldson & John R. Penrod, 2007. "Costs of Rheumatoid Arthritis: New Estimates from the Human Capital Method and Comparison to the Willingness-to-Pay Method," Medical Decision Making, , vol. 27(2), pages 138-150, March.
    • Handle: RePEc:sae:medema:v:27:y:2007:i:2:p:138-150
    DOI: 10.1177/0272989X06297389
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/0272989X06297389
    Download Restriction: no
    File URL: https://libkey.io/10.1177/0272989X06297389?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Elise H. Golan & Mordechai Shechter, 1993. "Contingent Valuation of Supplemental Health Care in Israel," Medical Decision Making, , vol. 13(4), pages 302-310, December.
    2. Milton C. Weinstein & Joanna E. Siegel & Alan M. Garber & Joseph Lipscomb & Bryan R. Luce & Willard G. Manning & George W. Torrance, 1997. "Productivity costs, time costs and health‐related quality of life: a response to the Erasmus Group," Health Economics, John Wiley & Sons, Ltd., vol. 6(5), pages 505-510, September.
    3. Thompson, M.S., 1986. "Willingness to pay and accept risks to cure chronic disease," American Journal of Public Health, American Public Health Association, vol. 76(4), pages 392-396.
    4. Werner B.F. Brouwer & Marc A. Koopmanschap & Frans F.H. Rutten, 1997. "Productivity costs in cost‐effectiveness analysis: numerator or denominator: a further discussion," Health Economics, John Wiley & Sons, Ltd., vol. 6(5), pages 511-514, September.
    5. Alan Diener & Bernie O'Brien & Amiram Gafni, 1998. "Health care contingent valuation studies: a review and classification of the literature," Health Economics, John Wiley & Sons, Ltd., vol. 7(4), pages 313-326, June.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Daniel E. Jonas & Louise B. Russell & Jon Chou & Michael Pignone, 2010. "Willingness‐to‐pay to avoid the time spent and discomfort associated with screening colonoscopy," Health Economics, John Wiley & Sons, Ltd., vol. 19(10), pages 1193-1211, October.
    2. Mennini, Francesco Saverio & Gitto, Lara, 2022. "Approaches to Estimating Indirect Costs in Healthcare: Motivations for Choice," MPRA Paper 112129, University Library of Munich, Germany.
    3. Caroline M Vass & Anne Barton & Katherine Payne, 2022. "Towards Personalising the Use of Biologics in Rheumatoid Arthritis: A Discrete Choice Experiment," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 15(1), pages 109-119, January.
    4. Hyeonseok Cho & Sung-Hee Oh & Hankil Lee & Hyun-Jai Cho & Hye-Young Kang, 2018. "The incremental economic burden of heart failure: A population-based investigation from South Korea," PLOS ONE, Public Library of Science, vol. 13(12), pages 1-12, December.
    5. Pierre-Alexandre Mahieu & Romain Craste & Bengt Kriström & Pere Riera, 2014. "Non-market valuation in France: An overview of the research activity," Working Papers hal-01087365, HAL.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Klose, Thomas, 1999. "The contingent valuation method in health care," Health Policy, Elsevier, vol. 47(2), pages 97-123, May.
    2. Richard D. Smith, 2003. "Construction of the contingent valuation market in health care:a critical assessment," Health Economics, John Wiley & Sons, Ltd., vol. 12(8), pages 609-628, August.
    3. Alan Diener & Bernie O'Brien & Amiram Gafni, 1998. "Health care contingent valuation studies: a review and classification of the literature," Health Economics, John Wiley & Sons, Ltd., vol. 7(4), pages 313-326, June.
    4. repec:cup:judgdm:v:2:y:2007:i::p:96-106 is not listed on IDEAS
    5. Brouwer, W. B. F. & van Exel, N. J. A. & Koopmanschap, M. A. & Rutten, F. F. H., 2002. "Productivity costs before and after absence from work: as important as common?," Health Policy, Elsevier, vol. 61(2), pages 173-187, August.
    6. Laura J. Damschroder & Peter A. Ubel & Jason Riis & Dylan M. Smith, 2007. "An alternative approach for eliciting willingness-to-pay: A randomized Internet trial," Judgment and Decision Making, Society for Judgment and Decision Making, vol. 2, pages 96-106, April.
    7. Aidan R. Vining & David L. Weimer, 2013. "An assessment of important issues concerning the application of benefit–cost analysis to social policy," Chapters, in: Scott O. Farrow & Richard Zerbe, Jr. (ed.), Principles and Standards for Benefit–Cost Analysis, chapter 1, pages 25-62, Edward Elgar Publishing.
    8. Weatherly, Helen & Drummond, Michael & Claxton, Karl & Cookson, Richard & Ferguson, Brian & Godfrey, Christine & Rice, Nigel & Sculpher, Mark & Sowden, Amanda, 2009. "Methods for assessing the cost-effectiveness of public health interventions: Key challenges and recommendations," Health Policy, Elsevier, vol. 93(2-3), pages 85-92, December.
    9. Brouwer, Werner B. F. & Koopmanschap, Marc A., 2000. "On the economic foundations of CEA. Ladies and gentlemen, take your positions!," Journal of Health Economics, Elsevier, vol. 19(4), pages 439-459, July.
    10. Paul Clay Sorum, 1999. "Measuring Patient Preferences by Willingness to Pay to Avoid," Medical Decision Making, , vol. 19(1), pages 27-37, January.
    11. Lee, Stephanie J. & Neumann, Peter J. & Churchill, W. Hallowell & Cannon, Marie E. & Weinstein, Milton C. & Johannesson, Magnus, 1997. "Patients' willingness to pay for autologous blood donation," Health Policy, Elsevier, vol. 40(1), pages 1-12, April.
    12. Obinna Onwujekwe, 2001. "Searching for a better willingness to pay elicitation method in rural Nigeria: the binary question with follow‐up method versus the bidding game technique," Health Economics, John Wiley & Sons, Ltd., vol. 10(2), pages 147-158, March.
    13. Marieke Krol & Arthur E. Attema & Job van Exel & Werner Brouwer, 2016. "Altruistic Preferences in Time Tradeoff," Medical Decision Making, , vol. 36(2), pages 187-198, February.
    14. Foreit, James R. & Foreit, Karen G. Fleischman, 2003. "The reliability and validity of willingness to pay surveys for reproductive health pricing decisions in developing countries," Health Policy, Elsevier, vol. 63(1), pages 37-47, January.
    15. Krol, Marieke & Brouwer, Werner, 2015. "Unpaid work in health economic evaluations," Social Science & Medicine, Elsevier, vol. 144(C), pages 127-137.
    16. Richard D. Smith, 2001. "The relative sensitivity of willingness‐to‐pay and time‐trade‐off to changes in health status: an empirical investigation," Health Economics, John Wiley & Sons, Ltd., vol. 10(6), pages 487-497, September.
    17. Lesong Conteh & Edith Patouillard & Margaret Kweku & Rosa Legood & Brian Greenwood & Daniel Chandramohan, 2010. "Cost Effectiveness of Seasonal Intermittent Preventive Treatment Using Amodiaquine & Artesunate or Sulphadoxine-Pyrimethamine in Ghanaian Children," PLOS ONE, Public Library of Science, vol. 5(8), pages 1-11, August.
    18. Marie-Odile Carrère & Nathalie Havet & Magali Morelle & Raphaël Remonnay, 2008. "Analyzing the determinants of willingness-to-pay values for testing the validity of the contingent valuation method. Application to home care compared to hospital care," Post-Print halshs-00303725, HAL.
    19. Icks, Andrea, 2021. "Self-care time and rating of health state in people with diabetes: Results from the population-based KORA survey in Germany," IBES Diskussionsbeiträge 234, University of Duisburg-Essen, Institute of Business and Economic Studie (IBES).
    20. Carmen Herrero Blanco & Juan D. Moreno Ternero, 2004. "Generalized Cost-Analysis Of Screening Programs," Working Papers. Serie AD 2004-18, Instituto Valenciano de Investigaciones Económicas, S.A. (Ivie).
    21. Franz Hackl & Gerald J. Pruckner, 2005. "Warm glow, free‐riding and vehicle neutrality in a health‐related contingent valuation study," Health Economics, John Wiley & Sons, Ltd., vol. 14(3), pages 293-306, March.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:27:y:2007:i:2:p:138-150. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.